By proceeding, you agree to our Terms of Use and Privacy Policy.
My work has focused primarily on exploring ways to modulate T cell activity for therapeutic benefit in both autoimmune and oncology settings.
Talks About #Autoimmunity #Immunotherapy #healthcare
Preferred Locations #NorthAmerica
With TCEs being studied in both hematological and solid tumors (39 and 34 trials respectively), there are now more than one hundred projects in the preclinical stage.
